Lecture 9 - Recombinant DNA Technology & GE
Lecture 9 - Recombinant DNA Technology & GE
Lecture 9 - Recombinant DNA Technology & GE
Microbial
Gene-cs
BI
302
Instructor:
Dr.
Nalina
Nadarajah
Email:
nnadarajah@centennialcollege.ca
Agenda
for
This
Week
• An
introduc-on
to
– Recombinant
DNA
technology
(online
module)
2
Overview
• Recombinant
DNA:
DNA
created
by
joining
together
pieces
of
DNA
from
different
sources
• Recombinant
DNA
technology
exploits
features
of
genes,
gene
expression,
and
DNA
enzymology
to
create
novel
DNA
molecules
for
study
• Although
natural
processes
such
as
crossing
over
produce
recombined
DNA
molecules,
the
term
usually
refers
to
ar4ficial
and
deliberate
recombina4on
of
pieces
of
DNA
from
different
organisms
that
are
not
found
together
in
nature
• Ac-ve
growth
since
the
early
1970s
• Gene-c
engineering
applies
recombinant
DNA
technology
to
problems
in
biology,
medicine,
and
agriculture
3
Overview
• Recombinant
DNA
technology
began
with
2
key
tools:
4
Overview
Cont.
• Foreign
DNA
is
spliced
into
a
vector
for
amplifica-on,
producing
a
clone
of
the
inserted
DNA
• Restric-on
endonucleases
cut
DNA
at
specific
target
sites
• Polymerase
chain
reac-on
(PCR)
can
be
used
for
specific
DNA
amplifica-on
• Labeled
single-‐stranded
DNA
or
RNA
can
be
used
as
a
probe
to
iden-fy
molecules
containing
its
base-‐pair
complement
• Virtually
any
nucleo-de
sequence,
including
restric-on
sites
can
be
mapped
• DNA
can
be
sequenced
• Transgenes
can
be
constructed
and
expressed
in
foreign
hosts
5
From
Bacteriophages
to
Restric-on
Enzymes
• mid
1960’s
–
Werner
Arber
showed
E.coli
produces
restric-on
endonucleases
(works
as
pair
of
molecular
scissors)
and
modifica+on
enzyme
which
adds
methyl
groups
to
DNA
hence
preven-ng
restric-on
endonuclease
ac-vity
• 1970
–
Hamilton
Smith
isolated
HindIII
from
Haemophilus
influenza
(blunt
end
cucer)
• 1973
–
Daniel
Nathans
created
first
restric-on
map
• 1975
–
Paul
Berg
created
first
recombinant
DNA
molecule
• Arber,
Smith
and
Nathans
shared
the
Nobel
Prize
in
1978
• Berg
won
the
Nobel
Prize
in
1980
6
Restric-on
Enzymes
• Produced
by
bacteria
as
a
defense
mechanism
against
infec-ons
by
viruses
- more
than
3500
restric-on
enzymes
have
been
iden-fied
8
Photo Source: Fig. 20-1 from Concepts of Genetics 10th Edition by Klug et al., 2012
Crea-on
of
Recombinant
DNA
9
Photo Source: Fig. 20-2 from Concepts of Genetics 10th Edition by Klug et al., 2012
Vectors
• Vectors
carry
DNA
molecules
to
be
cloned
10
Key
Proper-es
of
Vectors
• Size
– must
be
small
enough
to
separate
easily
• Mul-ple
cloning
sites
(MCS)
– a
stretch
of
DNA
with
recogni-on
sequences
for
common
restric-on
enzymes
• Origin
of
replica-on
(ori)
– DNA
sequence
at
which
replica-on
is
ini-ated
• Selectable
marker
genes
– allow
for
selec-on
and
iden-fica-on
of
transformed
bacteria
• RNA
polymerase
promoter
sequences
– place
where
RNA
polymerase
binds
to
begin
transcrip-on
• DNA
sequencing
primer
sequences
– known
sequence
that
allows
sequencing
of
cloned
DNA
11
Examples
of
Vectors
1. Bacterial
plasmids
2. Bacteriophage
vectors
3. Cosmid
vectors
4. Bacterial
ar-ficial
chromosomes
(BACs)
5. Yeast
ar-ficial
chromosomes
(YACs)
6. Tumor-‐inducing
(Ti)
vectors
12
1.
Bacterial
Plasmid
Vectors
• First
vectors
developed
and
s-ll
widely
used
• Plasmid
DNA
is
circular,
double
stranded,
self-‐replica-ng
DNA
that
scien-sts
can
manipulate
to
carry
and
clone
other
pieces
of
DNA
– found
primarily
in
bacteria
13
Two
Plasmids
as
Vectors
for
DNA
Cloning
ampR tetR
14
Nega4ve
Selec4on
–
pBR322
15
Posi4ve
Selec4on
–
pUC
vector
16
Cloning
with
Bacterial
Plasmid
Photo Source: Fig. 20-5 from Concepts of Genetics 10th Edition by Klug et al., 2012
Posi4ve
Selec4on:
pUC
vector
X-gal screening 17
2.
Phage
Vectors
(λ)
• whether DNA ss or ds
• e.g. M13 ss; λ ds
• size of donor DNA
• less than 1-2 kb in M13
• upto 15 kb in λ 18
3.
Cosmid
Vectors
• For
the
cloning
of
large
inserts
– 35
–
45
kb
inserts
• Hybrids
of
phage
λ
and
bacterial
plasmid
– composed
of
the
cos
site
of
phage
λ
inserted
into
a
plasmid
– cos
sites
are
necessary
for
packaging
of
phage
DNA
into
phage
par-cles
– λ
used
as
a
“syringe”
to
insert
the
insert
into
E.coli
• Once
inside
the
bacterial
cell,
cosmids
replicate
as
plasmids
19
An
Example
of
a
Cosmid
Vector
20
4.
Bacterial
Ar-ficial
Chromosomes
(BACs)
• To
clone
large
fragments
of
DNA
• BACs
are
large,
but
low
copy
number
(only
1-‐2
copies/
cell)
• BACs
are
based
on
F
factor
• Inserts
can
be
100
–
300
kb
• Contains
– origin
of
replica-on
– selectable
marker
gene
– mul-ple
cloning
sites
21
5.
Yeast
Ar-ficial
Chromosomes
(YACs)
• YACs
can
be
used
to
express
eukaryo-c
proteins
that
require
post-‐transla-onal
modifica-on
• Inserts
can
be
of
several
100
kb
(up
to
2000
kb)
• Disadvantages:
– less
stable
than
BAC
– producing
"chimeric
effects”
– ar-facts
where
the
sequence
of
the
cloned
DNA
actually
corresponds
not
to
a
single
genomic
region
but
to
mul-ple
regions.
• chimerism
due
to
co-‐liga-on
of
mul-ple
genomic
segments
into
a
single
YAC
or
recombina-on
of
two
or
more
YACs
transformed
in
the
same
host
Yeast
cell
22
An
Example
of
YAC
23
6.
Ti
Vector
for
Plant
Cells
• Agrobacterium
tumefaciens
(now
known
as
Rhizobium
radiobacter)
can
be
used
to
transform
plant
cells
with
T-‐DNA
containing
foreign
DNA
• The
T-‐DNA
and
insert
integrate
into
the
plant
genome
• The
plant
cells
can
be
grown
in
-ssue
culture
and
eventually
regenerate
a
mature
plant
carrying
a
foreign
gene
Animation
24
Cloning
Vectors
Vector
Form
of
DNA
Host
Capacity
Uses
Plasmid
Circular
E.
coli
<15
kb
subcloning
&
cDNA
libraries
Lambda
Linear
phage
E.
coli
<23
kb
cDNA
&
chromosome
genomic
libraries
Cosmid
Circular
E.
coli
30-‐45
kb
Genomic
libraries
BAC
Bacterial
E.
coli
100-‐300
kb
Genomic
chromosome
libraries
YAC
Yeast
S.
cerevisiae
250-‐2000
kb
Genomic
chromosome
libraries
25
Replica-ng
Recombinant
Molecules
• Need
many
copies
in
purified
form
• In
general,
there
are
2
ways
to
produce
large
quan--es
of
single
recombinant
molecule:
– chemically
• selec-vely
replicate
recombinant
DNA
molecule
in
a
test
tube
• e.g.
PCR
– biologically
• selec-ve
replica-on
machinery
of
bacterial
or
simple
eukaryo-c
cells
to
do
the
job
for
us
by
“tricking”
those
cells
into
replica-ng
a
recombinant
DNA
molecule
of
interest
26
Polymerase
Chain
Reac-on
(PCR)
• Developed
by
Kary
Mullis
in
1986
(Nobel
Prize
in
1993)
• PCR
copies
a
specific
DNA
sequence
through
in
vitro
reac-ons
that
can
amplify
target
DNA
sequences
present
in
very
small
quan--es
• Principle:
DNA
made
in
one
amplifica-on
cycle
is
used
as
template
in
subsequent
cycle
– heat
denatura-on
to
yield
single-‐stranded
DNA
– annealing
of
primers
(oligonucleo-des)
to
single-‐stranded
DNA
– extension
of
primers
by
thermostable
DNA
polymerase
• Highly
sensi-ve,
requiring
as
licle
as
one
copy
of
single-‐
stranded
DNA
as
ini-al
template
27
Polymerase
Chain
Reac-on
(PCR)
• PCR
requires
two
oligonucleo-de
primers
- one
complementary
to
the
3'
end
of
one
strand
of
the
DNA
to
be
amplified
- other
complementary
to
the
3'
end
of
the
other
strand
29
Limita-ons
of
PCR
30
Applica-ons
of
PCR
• Primers
can
be
designed
to
dis-nguish
1
bp
difference
in
targets
– detect
muta-ons,
gene-c
disorders
• Important
for
studying
samples
from
single
cells
– fossils,
crime
scenes
• Can
explore
uncharacterized
DNA
regions
adjacent
to
known
regions
• RT-‐PCR
is
a
powerful
tool
for
studying
gene
expression
• Quan-ta-ve
real-‐-me
PCR
(qPCR)
– powerful
and
rapid
technique
in
quan-ta-vely
measuring
gene
expression
31
Selec-ve
Replica-on
inside
a
Host
Cell
• Requires
use
of
cloning
vector
or
ar-ficial
chromosome
• Recombinant
molecule
must
enter
host
cell
• Recombinant
molecule
must
efficiently
replicate
• Replicated
recombinant
molecule
must
be
recovered
from
host
clone
• Many
commercial
products
available
• Transforma-on
into
expression
system
– bacterial
cell,
e.g.,
E.
coli
– eukaryo-c
cell,
e.g.,
yeast
32
33
Host
Cells
for
Cloning
Vectors
• Widely
used
prokaryo-c
host:
E.
coli
• Widely
used
eukaryo-c
host:
Saccharomyces
cerevisiae
– Why?
– it
can
be
grown
easily
– its
gene-cs
have
been
studied
intensively
– its
genome
has
been
sequenced
– it
can
poscransla-onally
modify
eukaryo-c
proteins
– it
is
considered
to
be
safe
34
35
Amplifica-on
and
Recovery
• Introducing
Foreign
DNA
into
Cell
1. transforma-on
for
plasmids
• Ca2+
and
heat-‐shock
• electropora-on
2. transduc-on
for
phages
• forma-on
of
recombinant
plasmid/chromosome
• produc-on
of
progeny
phages
carrying
the
recombinant
DNA
molecule
37
Amplifica-on
and
Recovery
Cont.
• Replica-on
of
vector
and
insert
u-lizing
host
cell
machinery
– presence
of
an
origin
of
DNA
replica-on
– exist
as
closed,
circular
ds
DNA
molecule
• Recovery
of
recombinant
DNA
– purifica-on
of
bacteriophages
• chemical
extrac-on
– purifica-on
of
extra
chromosomal
plasmids
or
recomb.
molecules
•
chemical
or
mechanical
extrac-on
• centrifuga-on
and/or
chromatography
for
plasmids
38
Recombinant
Libraries
• Collec-ons
of
cloned
sequences
• Ideally,
a
genomic
library
contains
at
least
one
copy
of
all
the
sequences
in
the
genome
of
interest
• Genomic
libraries
are
constructed
by
cusng
genomic
DNA
with
a
restric-on
enzyme
and
liga-ng
the
fragments
into
vectors
• The
choice
of
vector
usually
depends
on
the
size
of
the
genome
• A
cDNA
library
contains
complementary
DNA
copies
made
from
the
mRNAs
present
in
a
cell
popula-on
and
represents
the
genes
that
are
transcrip-onally
ac-ve
at
the
-me
the
cells
were
collected
for
mRNA
isola-on
39
cDNA
Library
• A
cDNA
library
is
prepared
by:
– isola-ng
mRNA
from
cells
– synthesizing
the
single
stranded
complementary
DNA
using
reverse
transcriptase
– then
using
RT-‐PCR
to
copy
the
single-‐stranded
DNA
into
double-‐stranded
DNA
– cloning
the
cDNA
molecules
into
a
vector
40
Genomic
and
cDNA
libraries
• Consist
of
collec-ons
of
DNA
molecules
• Genomic
library
consists
of
fragments
of
genome
– oten
constructed
from
par-al
restric-on
digests
– typically
mul-fold
representa-on
of
inserts
– contain
introns
and
regulatory
sequences
• cDNA
libraries
consist
of
DNA
derived
from
mRNA
popula-on
of
cell
types
or
-ssue
– limited
to
transcribed
genes
• not
all
mRNAs
are
expressed
at
any
given
-me
– introns
and
flanking
regulatory
sequences
absent
41
Iden-fying
DNA
Molecules
• It
is
oten
a
challenge
to
iden-fy
desired
gene
in
library
of
thousands
of
clones
• Using
nucleo-de
probes
– principle
based
on
base-‐pair
complementarity
– colonies
or
phage
plaques
are
transferred
to
membrane,
lysed
and
DNA
is
denatured
– probe
is
applied
to
membrane
• labeled
with
radioac-ve
isotope
or
fluorescent
dye
• probe
forms
double
helix
with
complementary
DNA
– hybrid
DNA
is
iden-fied
in
autoradiogram
or
by
exposure
to
exci-ng
wavelength
of
light
42
43
Reference
• Chapter
20
&
22
from
Concepts
of
Gene-cs,
10th
Edi-on
(2012)
by
Klug,
Cummings,
Spencer
and
Palladino
• Chapter
17
from
Gene-cs:
an
integrated
approach
• Chapter
8
from
Modern
Gene-c
Analysis
44
Gene-c
Engineering
• Gene-c
engineering
is
where
recombinant
DNA
(rDNA)
technology
is
used
to
introduce
desirable
traits
into
organisms
-‐-‐>
alter
genotype
of
organism
• A
gene-cally
engineered
(GE)
plant/
animal
contains
a
rDNA
construct
producing
a
new
trait
• Conven-onal
breeding
methods
have
long
been
used
to
produce
desirable
traits
in
plants/animals,
GE
is
a
much
more
targeted
method
• Engineered
genes
(transgenes)
are
used
to
construct
transgenic
organisms
• Numerous
applica-ons
in
addi-on
to
study
of
genes
45
Applica-ons
of
Gene-c
Engineering
1. Medicine
&
Healthcare
– produc-on
of
hormones,
biochemicals,
vaccines
2. Molecular
biology/
research
3. Diagnos-cs
4. Agriculture
– golden
rice
– herbicide-‐resistant
crops
(Roundup™)
– insect-‐resistant
crops
(Bt
toxin)
5. Animals
&
Humans
46
GE
in
Medicine
• Produc-on
of
human
insulin
in
E.coli
(humulin)
Discovery of insulin –
Nobel prize in 1923
47
GE
in
Medicine
• Produc-on
of
human
insulin
in
E.coli
(humulin)
• Produc-on
of
angiosta-n
and
endosta-n
(blocks
the
growth
of
new
blood
vessels)
in
Pichia
Pastoris
(yeast)
• Factor
VIII
&
Factor
IX
–
produced
in
cell
culture
for
the
treatment
of
Haemophilia
A
and
B,
respec-vely
• Erythropoie-n
(EPO)
–
produced
in
cell
culture
for
the
treatment
of
anaemia
• Hormones:
– HGH
in
E.coli
– human
parathyroid
hormone
in
E.coli
– Oxytocin
in
E.coli
48
49
Self-‐Replica-ng
Synthe-c
Microbes
• Announcement
of
synthe-c
bacteria
on
May
20,
2010
(Gibson
DG
et
al.
"Crea-on
of
a
Bacterial
Cell
Controlled
by
a
Chemically
Synthesized
Genome"
Science
Express
20
May
2010;
pp.
1-‐7)
Published by AAAS
Gene-c
Engineering:
Plants
• Considerable
agricultural
importance
• Considerable
controversy
regarding
health
and
environmental
safety
– recombinant
plants
oten
referred
to
as
GMOs,
gene-cally
modified
organisms
– argument
that
long-‐term
effects
are
unknown
53
Gene-cally
Modified
(GM)
Food
Feeding
7.2
billion
people
on
earth
Poten-al
risk
to
human
health?
-‐-‐>
-‐
worldwide
grain
produc-on
by
260%
from
increased
obesity
and
type
II
diabetes
in
last
1950
to
1990
50
years?
Disease/
frost/
draught
resistant
crops
-‐-‐>
Ecological
disrup-on
by
hybridizing
with
less
chemical
pes-cide
use
-‐-‐>
less
na-ve
plants
(gene-c
drit
or
gene-c
environmental
damage
-‐-‐>
less
pollu-on
in
trespass)
rivers
&
streams
Nutri-onally
enhanced
food
(golden
rice)
&
Developing
countries
are
made
dependent
edible
vaccines
–
bananas
or
potatoes
on
developed
countries’
mul-na-onal
containing
vaccines
companies
Ripen
slower
and
last
longer
during
shipping
Unintended
harm
to
other
organisms
-‐-‐>
less
food
wastage
54
Gene-c
Engineering:
Plants
• Two
major
methods
for
transforma-on
1. Ti
plasmid
from
Agrobacterium
tumefaciens
• upon
infec-on
of
plant
with
bacteria
containing
recombinant
Ti
plasmids,
the
Ti
plasmids
are
transferred
and
inserted
into
host
plant
genome
55
Infec-on
by
A.
tumefaciens
56
E.g.
Transgenic
Tobacco
Plants
58
Gene-c
Engineering:
Animals
• Numerous
model
systems
and
applica-ons
– Three
methods
of
crea-on
of
transgenic
animals:
1. DNA
microinjec-on
2. Retrovirus-‐mediated
gene
transfer
3. Embryonic
stem
cell-‐mediated
gene
transfer
60
Gene-c
Engineering:
Animals
• Uses
– ANDi:
the
first
transgenic
Rhesus
monkey
with
gfp
gene
– pets
(GloFish)
–
may
be
modified
to
be
used
for
pollu-on
detec-on?
– research
–
understanding
specific
gene
func-on
(fruit
flies)
– reducing
pollu-on
(Enviropig
excretes
from
30
to
70%
less
phosphorus
in
manure)
– dairy
cows
producing
human
breast
milk
63
Types
of
Gene
Therapy
in
Mammals
64
Soma-c
Cell
Human
Gene
Therapy
• in
clinical
trials
• First
case
-‐
A
4
year
old
girl
in
1990
in
US
– adenosine
deaminase
(ADA)
deficiency,
a
gene-c
disease
à
severe
combined
immunodeficiency
disease
(SCID)
65
Risks
of
Human
Gene
Therapy
• 18-‐year-‐old
American
(Jesse
Gelsinger)
became
the
first
person
to
die
from
gene-‐therapy
research
– ornithine
transcarbamoylase
(OTC)
deficiency,
a
metabolic
disorder
à
problem
with
elimina-on
of
ammonia
– Jesse
had
par-al
OTC
deficiency
à
manage
with
diet
&
meds
– signed
up
for
human
gene
therapy
trials
at
U
of
Pennsylvania
– Sept.
13
’99
-‐
infusion
of
correc-ve
OTC
gene
encased
in
acenuated
recombinant
adenoviral
vector
– he
experienced
a
severe
immune
reac-on
to
the
vector
à
died
4
days
later
• Three
children
died
in
June
2020
from
gene
therapy
for
their
rare
muscle
disease
Germ-‐Line
Human
Gene
Therapy
71
Addi-onal
Informa-on
• Video:
How
to
use
a
gene
gun
– hcps://youtu.be/gnz5zlzsRYw
72